Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mike Sathekge

Showing results (81-90 of 127) with videos related to

Pageof 13
Sort By:
Seminars in Nuclear Medicine|September 27, 2025
Nectin-4, Bladder Cancer, and Nuclear Medicine: A Theranostic FrontierJoseph Kabunda, Honest Ndlovu, Karishma Singh, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 28, 2017
Impact of <sup>68</sup>Ga-Prostate-Specific Membrane Antigen PET/CT on Prostate Cancer ManagementAsim Afaq, Suliman Alahmed, Shih-Hsin Chen, et al.
Journal of Neuroendocrinology|January 8, 2025
Synthesis and characterisation of DOTA-kisspeptin-10 as a potential gallium-68/lutetium-177 pan-tumour radiopharmaceuticalJanke Kleynhans, Robert Reeve, Cathryn H S Driver, et al.
Pharmaceutics|February 26, 2025
An Insight to Nanoliposomes as Smart Radiopharmaceutical Delivery Tools for Imaging Atherosclerotic Plaques: Positron Emission Tomography ApplicationsReabetswe Sebatana, Kahwenga D Kudzai, Allan Magura, et al.
Cancers|July 24, 2021
Target Heterogeneity in Oncology: The Best Predictor for Differential Response to Radioligand Therapy in Neuroendocrine Tumors and Prostate CancerAmeya D Puranik, Clarisse Dromain, Neil Fleshner, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 21, 2018
<sup>225</sup>Ac-PSMA-617 in chemotherapy-naive patients with advanced prostate cancer: a pilot studyMike Sathekge, Frank Bruchertseifer, Otto Knoesen, et al.
EJNMMI Radiopharmacy and Chemistry|November 6, 2023
<sup>89</sup>Zr-leukocyte labelling for cell trafficking: in vitro and preclinical investigationsMaryke Kahts, Hua Guo, Harikrishna Kommidi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 27, 2019
Correction to: <sup>225</sup>Ac-PSMA-617 in chemotherapy-naive patients with advanced prostate cancer: a pilot studyMike Sathekge, Frank Bruchertseifer, Otto Knoesen, et al.
Histology and Histopathology|April 14, 2020
PSMA expression on neovasculature of solid tumorsChristophe Van de Wiele, Mike Sathekge, Bart de Spiegeleer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 23, 2017
Intraindividual Comparison of <sup>18</sup>F-PSMA-1007 and <sup>18</sup>F-DCFPyL PET/CT in the Prospective Evaluation of Patients with Newly Diagnosed Prostate Carcinoma: A Pilot StudyFrederik L Giesel, Leon Will, Ismaheel Lawal, et al.
Pageof 13

Showing results (81-90 of 127) with videos related to

Sort By:
Pageof 13
Seminars in Nuclear Medicine|September 27, 2025
Nectin-4, Bladder Cancer, and Nuclear Medicine: A Theranostic FrontierJoseph Kabunda, Honest Ndlovu, Karishma Singh, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 28, 2017
Impact of <sup>68</sup>Ga-Prostate-Specific Membrane Antigen PET/CT on Prostate Cancer ManagementAsim Afaq, Suliman Alahmed, Shih-Hsin Chen, et al.
Journal of Neuroendocrinology|January 8, 2025
Synthesis and characterisation of DOTA-kisspeptin-10 as a potential gallium-68/lutetium-177 pan-tumour radiopharmaceuticalJanke Kleynhans, Robert Reeve, Cathryn H S Driver, et al.
Pharmaceutics|February 26, 2025
An Insight to Nanoliposomes as Smart Radiopharmaceutical Delivery Tools for Imaging Atherosclerotic Plaques: Positron Emission Tomography ApplicationsReabetswe Sebatana, Kahwenga D Kudzai, Allan Magura, et al.
Cancers|July 24, 2021
Target Heterogeneity in Oncology: The Best Predictor for Differential Response to Radioligand Therapy in Neuroendocrine Tumors and Prostate CancerAmeya D Puranik, Clarisse Dromain, Neil Fleshner, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 21, 2018
<sup>225</sup>Ac-PSMA-617 in chemotherapy-naive patients with advanced prostate cancer: a pilot studyMike Sathekge, Frank Bruchertseifer, Otto Knoesen, et al.
EJNMMI Radiopharmacy and Chemistry|November 6, 2023
<sup>89</sup>Zr-leukocyte labelling for cell trafficking: in vitro and preclinical investigationsMaryke Kahts, Hua Guo, Harikrishna Kommidi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 27, 2019
Correction to: <sup>225</sup>Ac-PSMA-617 in chemotherapy-naive patients with advanced prostate cancer: a pilot studyMike Sathekge, Frank Bruchertseifer, Otto Knoesen, et al.
Histology and Histopathology|April 14, 2020
PSMA expression on neovasculature of solid tumorsChristophe Van de Wiele, Mike Sathekge, Bart de Spiegeleer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 23, 2017
Intraindividual Comparison of <sup>18</sup>F-PSMA-1007 and <sup>18</sup>F-DCFPyL PET/CT in the Prospective Evaluation of Patients with Newly Diagnosed Prostate Carcinoma: A Pilot StudyFrederik L Giesel, Leon Will, Ismaheel Lawal, et al.
Pageof 13